In addition our study further confirmed that high levels of FOXD1, ITGA6 and SERPINE1 were associated with HER2-overexpressing breast cancer cells resistant to trastuzumab (Fig. 5a) and they were regulated by acetylation of H3K27 and H3K18 (Fig. 5b,c). Here, ERBB2 is linked to breast carcinoma.